Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$276.39 - $362.25 $3.89 Million - $5.1 Million
-14,075 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$281.08 - $444.25 $380,582 - $601,514
1,354 Added 10.64%
14,075 $4.58 Million
Q3 2018

Nov 09, 2018

BUY
$354.53 - $449.75 $106,713 - $135,374
301 Added 2.42%
12,721 $5.72 Million
Q2 2018

Aug 08, 2018

BUY
$278.07 - $446.21 $271,396 - $435,500
976 Added 8.53%
12,420 $5.08 Million
Q1 2018

May 10, 2018

SELL
$192.49 - $295.85 $3.59 Million - $5.52 Million
-18,654 Reduced 61.98%
11,444 $3.33 Million
Q4 2017

Feb 08, 2018

SELL
$168.78 - $199.74 $1.43 Million - $1.69 Million
-8,470 Reduced 21.96%
30,098 $5.64 Million
Q3 2017

Oct 31, 2017

BUY
$145.39 - $168.6 $1.2 Million - $1.39 Million
8,267 Added 27.28%
38,568 $6.5 Million
Q2 2017

Aug 09, 2017

BUY
N/A
30,301
30,301 $4.34 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Artemis Investment Management LLP Portfolio

Follow Artemis Investment Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.